ABBV Maintained by Citigroup -- Price Target Raised to $260
ABBV Maintained by Citigroup -- Price Target Raised to $260 GuruFocus
Covered in this story
What has happened since
- AbbVie is up 7.2% since this was published, 77 days ago.
- Citigroup is down 4.0% since this was published, 77 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Citi’s $260 target on $ABBV is on the record and being tracked to Jul 2027 (12-month default), scored on the close that day.
Citi’s track record →Analyst targets on AbbVie
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ABBV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on AbbVie →Dalsna Finance is currently tracking 50 stories mentioning AbbVie, the earliest published 15 May 2026.
Summary aggregated from GuruFocus's public RSS feed. The full reporting belongs to GuruFocus — please read it on their site.